Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Operating Expenses (2016 - 2025)

Xtant Medical Holdings has reported Operating Expenses over the past 16 years, most recently at $19.5 million for Q3 2025.

  • Quarterly Operating Expenses fell 3.15% to $19.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $58.3 million through Dec 2025, down 27.4% year-over-year, with the annual reading at $80.3 million for FY2024, 22.35% up from the prior year.
  • Operating Expenses was $19.5 million for Q3 2025 at Xtant Medical Holdings, down from $19.7 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $21.5 million in Q2 2024 and troughed at $8.1 million in Q1 2021.
  • The 5-year median for Operating Expenses is $13.8 million (2023), against an average of $14.7 million.
  • Year-over-year, Operating Expenses dropped 26.24% in 2021 and then soared 108.8% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $9.6 million in 2021, then rose by 4.41% to $10.0 million in 2022, then surged by 108.8% to $20.9 million in 2023, then dropped by 14.5% to $17.9 million in 2024, then grew by 8.63% to $19.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Operating Expenses are $19.5 million (Q3 2025), $19.7 million (Q2 2025), and $19.2 million (Q1 2025).